Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chloe Jennifer Jordan, Ph.D.

Title
Institution
Department
Address
Profile Picture

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Han X, Liang Y, Hempel B, Jordan CJ, Shen H, Bi GH, Li J, Xi ZX. Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice. J Neurosci. 2023 01 18; 43(3):373-385. PMID: 36517243; PMCID: PMC9864584.
    Citations:    Fields:    Translation:AnimalsCells
  2. Hupalo S, Jordan CJ, Bowen T, Mahar J, Yepez E, Kunath L, Timm S, Martinowich K, Carlezon WA, Monteggia LM, George TP. NPP's approach toward improving rigor and transparency in clinical trials research. Neuropsychopharmacology. 2023 Feb; 48(3):429-431. PMID: 36038779; PMCID: PMC9852433.
    Citations: 1     Fields:    
  3. Hupalo S, Martinowich K, Carlezon WA, Jordan CJ. Neuropsychopharmacology (NPP) 2020 report on gender balance among corresponding authors and reviewers: before and during the COVID-19 pandemic. Neuropsychopharmacology. 2022 04; 47(5):973-975. PMID: 35190705; PMCID: PMC8860368.
    Citations:    Fields:    Translation:HumansPHPublic Health
  4. You ZB, Gardner EL, Galaj E, Moore AR, Buck T, Jordan CJ, Humburg BA, Bi GH, Xi ZX, Leggio L. Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approaches. Mol Psychiatry. 2022 04; 27(4):2171-2181. PMID: 35064236; PMCID: PMC9133122.
    Citations:    Fields:    Translation:Animals
  5. Jordan CJ, Xi ZX. Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals. Front Neurosci. 2021; 15:811192. PMID: 35095405; PMCID: PMC8789752.
    Citations: 1     
  6. Wise RA, Jordan CJ. Dopamine, behavior, and addiction. J Biomed Sci. 2021 Dec 02; 28(1):83. PMID: 34852810.
    Citations: 7     Fields:    Translation:AnimalsCells
  7. Gomez JL, Bonaventura J, Keighron J, Wright KM, Marable DL, Rodriguez LA, Lam S, Carlton ML, Ellis RJ, Jordan CJ, Bi GH, Solis O, Pignatelli M, Bannon MJ, Xi ZX, Tanda G, Michaelides M. Synaptic Zn2+ potentiates the effects of cocaine on striatal dopamine neurotransmission and behavior. Transl Psychiatry. 2021 11 08; 11(1):570. PMID: 34750356; PMCID: PMC8575899.
    Citations: 2     Fields:    Translation:AnimalsCells
  8. Velez ML, Jordan C, Jansson LM. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS. Neurotoxicol Teratol. 2021 Nov-Dec; 88:107032. PMID: 34600100.
    Citations: 2     Fields:    Translation:Humans
  9. Velez ML, Jordan CJ, Jansson LM. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Neurotoxicol Teratol. 2021 Nov-Dec; 88:107020. PMID: 34419619; PMCID: PMC8578408.
    Citations: 1     Fields:    Translation:Humans
  10. Jordan CJ, Wise R, Xi ZX. Pharmacology in the age of circuit neuroscience: Illuminating the neural mechanisms of reward, drug use and addiction and enlightening the future of translational research. Pharmacol Biochem Behav. 2021 07; 206:173187. PMID: 33872665; PMCID: PMC9305315.
    Citations:    Fields:    Translation:HumansAnimals
  11. Jordan CJ, Martinowich K, Carlezon WA. Neuropsychopharmacology (NPP): update on relationships between online attention and citation counts. Neuropsychopharmacology. 2021 05; 46(6):1061-1063. PMID: 33603138; PMCID: PMC8115066.
    Citations:    Fields:    
  12. Humburg BA, Jordan CJ, Zhang HY, Shen H, Han X, Bi GH, Hempel B, Galaj E, Baumann MH, Xi ZX. Optogenetic brain-stimulation reward: A new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre mice. Addict Biol. 2021 07; 26(4):e13005. PMID: 33538103; PMCID: PMC9308103.
    Citations: 7     Fields:    Translation:AnimalsCells
  13. Jilani SM, Jordan CJ, Jansson LM, Davis JM. Definitions of neonatal abstinence syndrome in clinical studies of mothers and infants: an expert literature review. J Perinatol. 2021 06; 41(6):1364-1371. PMID: 33514878; PMCID: PMC8225507.
    Citations: 4     Fields:    Translation:Humans
  14. Newman AH, Ku T, Jordan CJ, Bonifazi A, Xi ZX. New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders. Annu Rev Pharmacol Toxicol. 2021 01 06; 61:609-628. PMID: 33411583; PMCID: PMC9341034.
    Citations: 12     Fields:    Translation:Humans
  15. Jordan CJ, Weiss SRB, Howlett KD, Freund MP. Introduction to the Special Issue on "Informing Longitudinal Studies on the Effects of Maternal Stress and Substance Use on Child Development: Planning for the HEALthy Brain and Child Development (HBCD) Study". Advers Resil Sci. 2020; 1(4):217-221. PMID: 33106790; PMCID: PMC7578232.
    Citations: 3     
  16. Galaj E, Han X, Shen H, Jordan CJ, He Y, Humburg B, Bi GH, Xi ZX. Dissecting the Role of GABA Neurons in the VTA versus SNr in Opioid Reward. J Neurosci. 2020 11 11; 40(46):8853-8869. PMID: 33046548.
    Citations: 23     Fields:    Translation:AnimalsCells
  17. Jordan CJ, Carlezon WA. Effects of the COVID-19 pandemic on gender representation among corresponding authors of Neuropsychopharmacology (NPP) manuscripts: submissions during January-June, 2020. Neuropsychopharmacology. 2021 01; 46(2):269-270. PMID: 32967001.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  18. Jordan CJ, He Y, Bi GH, You ZB, Cao J, Xi ZX, Newman AH. (±)VK4-40, a novel dopamine D3 receptor partial agonist, attenuates cocaine reward and relapse in rodents. Br J Pharmacol. 2020 10; 177(20):4796-4807. PMID: 32851643; PMCID: PMC7520435.
    Citations: 4     Fields:    Translation:Animals
  19. Jordan CJ, Palmer AA. Virtual meetings: A critical step to address climate change. Sci Adv. 2020 Sep; 6(38). PMID: 32938670.
    Citations: 1     Fields:    
  20. Jordan CJ, Palmer AA. ACNP efforts toward reducing climate change. Neuropsychopharmacology. 2020 12; 45(13):2137-2138. PMID: 32791512.
    Citations:    Fields:    
  21. Jordan CJ, Feng ZW, Galaj E, Bi GH, Xue Y, Liang Y, McGuire T, Xie XQ, Xi ZX. Xie2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents. Neuropharmacology. 2020 10 01; 176:108241. PMID: 32712273.
    Citations: 5     Fields:    Translation:AnimalsCells
  22. Mereu M, Hiranita T, Jordan CJ, Chun LE, Lopez JP, Coggiano MA, Quarterman JC, Bi GH, Keighron JD, Xi ZX, Newman AH, Katz JL, Tanda G. Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions. Neuropsychopharmacology. 2020 08; 45(9):1518-1526. PMID: 32340023.
    Citations: 4     Fields:    Translation:AnimalsCells
  23. Jordan CJ, Humburg BA, Thorndike EB, Shaik AB, Xi ZX, Baumann MH, Newman AH, Schindler CW. Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats. J Pharmacol Exp Ther. 2019 12; 371(3):602-614. PMID: 31562201.
    Citations: 13     Fields:    Translation:Animals
  24. Jordan CJ, Carlezon WA. NPP (Neuropsychopharmacology): update on gender balance in journal function. Neuropsychopharmacology. 2019 12; 44(13):2145-2148. PMID: 31480071; PMCID: PMC6898399.
    Citations: 1     Fields:    Translation:Humans
  25. Jordan CJ, Neigh GN, Carlezon WA. Neuropsychopharmacology (NPP): relationships between online attention and citation counts. Neuropsychopharmacology. 2019 08; 44(9):1513-1515. PMID: 31146279.
    Citations:    Fields:    Translation:Humans
  26. Jordan CJ, Cao J, Newman AH, Xi ZX. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine. Neuropharmacology. 2019 11 01; 158:107609. PMID: 31009632.
    Citations: 30     Fields:    Translation:Humans
  27. Jordan CJ, Humburg B, Rice M, Bi GH, You ZB, Shaik AB, Cao J, Bonifazi A, Gadiano A, Rais R, Slusher B, Newman AH, Xi ZX. The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents. Neuropharmacology. 2019 11 01; 158:107597. PMID: 30974107.
    Citations: 29     Fields:    Translation:AnimalsCells
  28. Newman AH, Cao J, Keighron JD, Jordan CJ, Bi GH, Liang Y, Abramyan AM, Avelar AJ, Tschumi CW, Beckstead MJ, Shi L, Tanda G, Xi ZX. Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders. Neuropsychopharmacology. 2019 07; 44(8):1435-1444. PMID: 30858517.
    Citations: 18     Fields:    Translation:AnimalsCells
  29. Jordan CJ, Xi ZX. Progress in brain cannabinoid CB2 receptor research: From genes to behavior. Neurosci Biobehav Rev. 2019 03; 98:208-220. PMID: 30611802.
    Citations: 62     Fields:    Translation:HumansAnimalsCells
  30. Freund N, Jordan CJ, Lukkes JL, Norman KJ, Andersen SL. Juvenile exposure to methylphenidate and guanfacine in rats: effects on early delay discounting and later cocaine-taking behavior. Psychopharmacology (Berl). 2019 Feb; 236(2):685-698. PMID: 30411140.
    Citations: 4     Fields:    Translation:Animals
  31. Gao JT, Jordan CJ, Bi GH, He Y, Yang HJ, Gardner EL, Xi ZX. Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats. Neuropsychopharmacology. 2018 12; 43(13):2615-2626. PMID: 30283001.
    Citations: 10     Fields:    Translation:Animals
  32. Jordan CJ, Carlezon WA. Neuropsychopharmacology (NPP): gender balance in journal function. Neuropsychopharmacology. 2019 01; 44(1):4-8. PMID: 30188510.
    Citations: 2     Fields:    Translation:Humans
  33. Zhan J, Jordan CJ, Bi GH, He XH, Gardner EL, Wang YL, Xi ZX. Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice. Neuropharmacology. 2018 10; 141:11-20. PMID: 30138692.
    Citations: 11     Fields:    Translation:Animals
  34. Jansson LM, Jordan CJ, Velez ML. Perinatal Marijuana Use and the Developing Child. JAMA. 2018 Aug 14; 320(6):545-546. PMID: 30014136.
    Citations: 9     Fields:    Translation:Humans
  35. He XH, Jordan CJ, Vemuri K, Bi GH, Zhan J, Gardner EL, Makriyannis A, Wang YL, Xi ZX. Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats. Acta Pharmacol Sin. 2019 Mar; 40(3):365-373. PMID: 29967454; PMCID: PMC6460369.
    Citations: 17     Fields:    Translation:Animals
  36. Zhang HY, Shen H, Jordan CJ, Liu QR, Gardner EL, Bonci A, Xi ZX. CB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodies. Acta Pharmacol Sin. 2019 Mar; 40(3):398-409. PMID: 29967455; PMCID: PMC6460367.
    Citations: 17     Fields:    Translation:AnimalsCells
  37. Jordan CJ, Xi ZX. Discovery and development of varenicline for smoking cessation. Expert Opin Drug Discov. 2018 07; 13(7):671-683. PMID: 29587555.
    Citations: 21     Fields:    Translation:HumansAnimals
  38. Li X, Peng XQ, Jordan CJ, Li J, Bi GH, He Y, Yang HJ, Zhang HY, Gardner EL, Xi ZX. mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism. Sci Rep. 2018 02 27; 8(1):3686. PMID: 29487381.
    Citations: 21     Fields:    Translation:Animals
  39. Jordan CJ, Andersen SL. Working memory and salivary brain-derived neurotrophic factor as developmental predictors of cocaine seeking in male and female rats. Addict Biol. 2018 05; 23(3):868-879. PMID: 28857460.
    Citations: 5     Fields:    Translation:Animals
  40. Jordan, C.J., Andersen, S.L. Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate (Ritalin) and Dopamine. In C. Byrne, S. Castelnovo, G. Tomalin, and J. Williams (Eds.). Reference Module in Neuroscience and Biobehavioral Psychology. 2016. View Publication.
  41. Jordan CJ, Andersen SL. Sensitive periods of substance abuse: Early risk for the transition to dependence. Dev Cogn Neurosci. 2017 06; 25:29-44. PMID: 27840157.
    Citations: 81     Fields:    Translation:Humans
  42. Jordan CJ, Lemay C, Dwoskin LP, Kantak KM. Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood. Psychopharmacology (Berl). 2016 Dec; 233(23-24):3891-3903. PMID: 27600990; PMCID: PMC5026317.
    Citations: 10     Fields:    Translation:Animals
  43. Jordan CJ, Taylor DM, Dwoskin LP, Kantak KM. Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood. Behav Brain Res. 2016 Jan 15; 297:165-79. PMID: 26467602; PMCID: PMC4679481.
    Citations: 12     Fields:    Translation:Animals
  44. Kantak KM, Barlow N, Tassin DH, Brisotti MF, Jordan CJ. Performance on a strategy set shifting task in rats following adult or adolescent cocaine exposure. Psychopharmacology (Berl). 2014 Dec; 231(23):4489-501. PMID: 24800898.
    Citations: 7     Fields:    Translation:Animals
  45. Jordan CJ, Harvey RC, Baskin BB, Dwoskin LP, Kantak KM. Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments. Drug Alcohol Depend. 2014 Jul 01; 140:25-32. PMID: 24811203.
    Citations: 18     Fields:    Translation:Animals
  46. Caldwell-Harris, CL, Jordan, CJ. Systemizing and special interests: Characterizing the continuum from neurotypical to autism spectrum disorder. Learning Individ Diff. 2014; 29:98-105. View Publication.
  47. Somkuwar SS, Jordan CJ, Kantak KM, Dwoskin LP. Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions. Neuropsychopharmacology. 2013 Dec; 38(13):2588-97. PMID: 23822950.
    Citations: 25     Fields:    Translation:Animals
  48. Harvey RC, Jordan CJ, Tassin DH, Moody KR, Dwoskin LP, Kantak KM. Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments. Behav Brain Res. 2013 May 01; 244:38-47. PMID: 23376704.
    Citations: 19     Fields:    Translation:Animals
  49. Szalay JJ, Jordan CJ, Kantak KM. Neural regulation of the time course for cocaine-cue extinction consolidation in rats. Eur J Neurosci. 2013 Jan; 37(2):269-77. PMID: 23106490.
    Citations: 10     Fields:    Translation:Animals
  50. Jordan CJ, Caldwell-Harris CL. Understanding differences in neurotypical and autism spectrum special interests through Internet forums. Intellect Dev Disabil. 2012 Oct; 50(5):391-402. PMID: 23025641.
    Citations: 16     Fields:    Translation:Humans
  51. Jordan CJ. Evolution of autism support and understanding via the World Wide Web. Intellect Dev Disabil. 2010 Jun; 48(3):220-7. PMID: 20597733.
    Citations: 9     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Jordan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (188)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.